美国购药新方式！为什么选择美国药品？

Pharmaceutical companies in the US are creating new medicines that seem miraculous. Previously incurable diseases such as hepatitis C and certain types of cancer are being cured with new wonder drugs like Harvoni and immunotherapies. Obtaining the best medication is the key to treatment in many diseases.

Unfortunately for patients in China, two major factors impact their access to the best medications.

First, the approval process for new drugs is up to 5 years behind the approval processes in the US. There are about 1,000 drugs that are simply unavailable to Chinese people but available in the US because the China FDA has not approved the drugs yet.

Second, the counterfeit rate for drugs in China is 20-50%. Quality control on counterfeit drugs varies considerably, and poor quality drugs kill people every year in China. The counterfeit rate for drugs in the US is much less than 1%, and patients could have more confidence in their treatment if they knew that the drug they were getting is high quality.

For years, Chinese patients only access to top medications from the US was by traveling to the US for a prescription which could then be taken back to China or shipped by a relative.

MORE Health has developed an innovative platform that allows you to have a clinical visit with one of our US doctors on our online platform. After reviewing your complete medical record and having a 15-30 minute video conference with you, our expert physicians can write a prescription for you which can be filled at any California pharmacy.

If you don’t want to travel to the US to pick up your medications, we can arrange for one of our experienced partner pharmacies to mail an up to one month supply of medication directly to your address in China.

If you’d like more information, please get in touch with our case management team.

中文翻译：

近年来，美国制药公司在新药研究与开发上取得了巨大的成果，之前被认为是无法治愈的疾病，如丙型肝炎和部分早期癌症疾病，随着突破性治疗方法的出现，如丙肝神药Harvoni、肿瘤免疫疗法等，让这些顽疾可以得到治愈。医疗权威认为，能够获得最好、最合适的药物是许多疾病治愈的关键因素。

虽然中国的制药行业取得了长足的进步，但由于政策不同和与美国研发水平的差距，使得中国的患者在试图获得国际最先进的药物时存在两个难题。

第一，中国对于新药品的审批流程比美国晚5年左右。这就导致了很多在美国可以使用的药品在中国却无法买到。目前，大约有1000种新药尚未通过中国食品药品监督管理局（CFDA）的上市批准，因此这些新药无法在中国大陆购买，仅能通过美国等海外途径获得。

第二，仿制药品和不合格药品在中国市场上占有20%-50%的比例，相比发达国家，这个比例是非常高的；且对于仿制药品和不合格药品的质量监督机制，中国也存在较大问题。有质量问题的药品不仅不会帮助患者治愈和恢复，反而会对患者造成更严重的健康问题。反观美国，类似的仿制或不合格药品在市场所占的比重低于1%，因此，如果患者有机会使用更有质量保证的药品，将进一步提高治愈的可能，并增加患者康复的信心。

由于地域的不便、语言的不同和医疗体系的差异，数年以来，只有极少数的中国患者可以通过赴美就医的方式获得美国医生的处方药，虽然是有效的方法，但成本高，连续性差。

现今，MORE Health已经开发出一套高效安全的远程医疗平台系统。通过这个系统，患者的国内主治医生可以与美国专家一起为患者进行远程会诊。患者还可以通过与美国专家视频会议的形式建立医患关系，并根据需要获得合法的电子处方，从而安全、合法、高效的获得美国处方药品。

如果您不想远赴重洋，赴美开药的话，MORE Health及其合作药房还可以为您提供药品国际递送服务和详尽的用药指导。一次邮寄的药品剂量通常为一个月的使用量，并可多次续配。